Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytosorbents Cor (NQ: CTSO ) 1.500 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,940 Open 1.500 Bid (Size) 1.500 (8) Ask (Size) 1.600 (1) Prev. Close 1.500 Today's Range 1.500 - 1.500 52wk Range 0.7000 - 2.150 Shares Outstanding 54,429,617 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update Today 7:00 EDT From CytoSorbents Via GlobeNewswire CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference August 27, 2024 From CytoSorbents Via GlobeNewswire Performance YTD +40.19% +40.19% 1 Month +47.06% +47.06% 3 Month +114.29% +114.29% 6 Month +65.02% +65.02% 1 Year -15.73% -15.73% More News Read More CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 16, 2024 From CytoSorbents Via GlobeNewswire Recap: CytoSorbents Q4 Earnings March 14, 2024 Via Benzinga CTSO Stock Earnings: CytoSorbents Beats EPS, Beats Revenue for Q2 2024 August 13, 2024 Via InvestorPlace CytoSorbents Reports Second Quarter 2024 Financial and Operational Results August 13, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Appoints Peter J. Mariani Chief Financial Officer August 13, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Report Second Quarter 2024 Operating and Financial Results August 07, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement August 01, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website July 29, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress July 17, 2024 From CytoSorbents Via GlobeNewswire Why CytoSorbents (CTSO) Stock Is Trading Higher July 02, 2024 Via Benzinga CytoSorbents Secures $20 Million Credit Facility July 02, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan June 24, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union June 13, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting June 05, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract June 04, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024 May 09, 2024 Via InvestorPlace CytoSorbents Reports First Quarter 2024 Results May 09, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe May 02, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Report First Quarter 2024 Operating and Financial Results April 26, 2024 From CytoSorbents Via GlobeNewswire STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting April 17, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023 March 14, 2024 Via InvestorPlace CytoSorbents Reports Fourth Quarter and Full Year 2023 Results March 14, 2024 From CytoSorbents Via GlobeNewswire Earnings Scheduled For March 14, 2024 March 14, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
